X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
X4 Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 20, 2021
X4 Pharmaceuticals reported fiscal year 2020 executive compensation information on April 20, 2021.
In 2020, three executives at X4 Pharmaceuticals received on average a compensation package of $1.6M, a 17% increase compared to previous year.
Average pay of disclosed executives at X4 Pharmaceuticals
Paula Ragan, Chief Executive Officer, received $2.5M in total, which increased by 1% compared to 2019. 67% of Ragan's compensation, or $1.7M, was in stock awards. Ragan also received $272K in non-equity incentive plan, $543K in salary, as well as $8.2K in other compensation.
Adam S. Mostafa, Chief Financial Officer, received a compensation package of $1.2M, which increased by 36% compared to previous year. 52% of the compensation package, or $613K, was in stock awards.
Derek Meisner, General Counsel, earned $1.1M in 2020.
Related executives
You may also like
Source: SEC filing on April 20, 2021.